Trial Profile
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Rivoceranib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 16 May 2018 New trial record